Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Assets Average (2022 - 2025)

Atara Biotherapeutics (ATRA) has disclosed Assets Average for 4 consecutive years, with $33.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets Average fell 74.2% year-over-year to $33.5 million, compared with a TTM value of $33.5 million through Sep 2025, down 74.2%, and an annual FY2024 reading of $137.3 million, down 49.33% over the prior year.
  • Assets Average was $33.5 million for Q3 2025 at Atara Biotherapeutics, down from $49.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $416.7 million in Q2 2022 and bottomed at $33.5 million in Q3 2025.
  • Average Assets Average over 4 years is $209.3 million, with a median of $171.3 million recorded in 2023.
  • The sharpest move saw Assets Average decreased 28.93% in 2024, then crashed 74.2% in 2025.
  • Year by year, Assets Average stood at $372.4 million in 2022, then tumbled by 52.43% to $177.1 million in 2023, then fell by 28.93% to $125.9 million in 2024, then plummeted by 73.36% to $33.5 million in 2025.
  • Business Quant data shows Assets Average for ATRA at $33.5 million in Q3 2025, $49.5 million in Q2 2025, and $85.6 million in Q1 2025.